Latest Financial Position News

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

Mount Ridley Mines has reported a substantial inferred mineral resource for heavy rare earths and scandium at its Western Australian project, underpinning its multi-element development strategy.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

Prairie Lithium has moved Pad #1 from groundwork to active building construction, backed by SaskPower's powerline installation and a binding Hydro Lithium offtake agreement that includes a A$10 million equipment contribution. First production is targeted for Q4 2026.

Aureka Limited extends its Victorian gold resource ambitions with strong drilling results at Irvine and Comstock, backed by fresh geophysical data and secured tenure.

Strata Minerals delivered strong maiden drilling results at its Zelica Gold Project, confirming consistent shallow high-grade gold mineralisation over a 1km strike. The company consolidated its landholding with the acquisition of Zelica South, extending the gold corridor to 10km and commencing follow-up exploration.

TrivarX has made significant strides in preparing its Stabl-Im stable isotope imaging platform for Phase 1 clinical trials, backed by strengthened leadership and a solid cash reserve of $2.91 million.

Accelerate Resources (ASX: AX8) has made significant strides in its dual-growth strategy, uncovering multiple gold mineralised corridors at Balagundi and defining a new high-grade manganese hub at Woodie Woodie North during the March 2026 quarter.

Clara Resources has completed acquisition of the Mareeba Gold Project, initiating modern exploration and refocusing its portfolio on Queensland gold assets while securing fresh capital and leadership changes.

Marquee Resources has significantly increased its Mt Clement inferred antimony resource and is advancing drilling and strategic partnerships to develop its flagship project.

Encounter Resources (ASX:ENR) has reported a major 83% increase in the Green deposit’s inferred niobium resource at its Aileron project, lifting the combined inferred mineral resource by 54%. Meanwhile, copper-gold drilling advances in the Paterson Province as the company targets Havieron-style systems.

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.